feed,title,long_url,short_url
Benzinga,Pivotal phase III clinical trial IND submission of the original innovative anticancer drug Chiauranib for the treatment of small cell lung cancer was accepted by the Center of Drug Evaluation of the NMPA,https://www.benzinga.com/pressreleases/21/01/n19093364/pivotal-phase-iii-clinical-trial-ind-submission-of-the-original-innovative-anticancer-drug-chiaura,https://j.mp/2LBEZx5
